| scholarly article | Q13442814 |
| P2093 | author name string | Yue Zhang | |
| Kun Zhao | |||
| Xiaodong Zhou | |||
| Hongzhi Zheng | |||
| Muqiong Li | |||
| Ruijiao Chang | |||
| P2860 | cites work | An overview of clinical and commercial impact of drug delivery systems | Q27007143 |
| Ultrasound exposure improves the targeted therapy effects of galactosylated docetaxel nanoparticles on hepatocellular carcinoma xenografts | Q28487464 | ||
| Galactosylated poly-L-lysine targeted microbubbles for ultrasound mediated antisense c-myc gene transfection in hepatocellular carcinoma cells | Q30411283 | ||
| Ultrasound-targeted microbubble destruction mediated herpes simplex virus-thymidine kinase gene treats hepatoma in mice | Q30477547 | ||
| Pharmacokinetics of liver-targeted docetaxel liposomes modified with 6-O-acyl-D-galactose esters in rabbits | Q33733562 | ||
| Hepatocellular carcinoma: the need for progress. | Q34414715 | ||
| Therapeutic applications of lipid-coated microbubbles. | Q35756608 | ||
| RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker | Q35786661 | ||
| A critical review of lipid-based nanoparticles for taxane delivery | Q36360764 | ||
| Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors | Q36644030 | ||
| A review of glycosylated carriers for drug delivery. | Q37991459 | ||
| Ultrasound targeted microbubble destruction increases capillary permeability in hepatomas. | Q50467347 | ||
| Tumor pH(e)-triggered charge-reversal and redox-responsive nanoparticles for docetaxel delivery in hepatocellular carcinoma treatment. | Q52918204 | ||
| Effectiveness of localized ultrasound-targeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model. | Q53638561 | ||
| An integrated set of methods for routine flow cytometric DNA analysis | Q70262320 | ||
| Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience | Q73446651 | ||
| The role of macroscopic classification in nodular-type hepatocellular carcinoma | Q74561285 | ||
| Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma | Q38040217 | ||
| The role of autophagy in liver cancer: molecular mechanisms and potential therapeutic targets | Q38083383 | ||
| Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liv | Q38101084 | ||
| Acoustic behavior of microbubbles and implications for drug delivery | Q38199325 | ||
| Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma. | Q38503687 | ||
| Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells | Q38835298 | ||
| A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells | Q38852201 | ||
| Cytotoxic activity of anticancer drugs on hepatocellular carcinoma cells in hypoxic-hyponutritional culture | Q38936508 | ||
| The antitumor effect of a new docetaxel-loaded microbubble combined with low-frequency ultrasound in vitro: preparation and parameter analysis | Q39192903 | ||
| Ultrasound-mediated targeted drug delivery generated by multifocal beam patterns: an in vitro study | Q39208276 | ||
| Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity. | Q39236369 | ||
| Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice | Q39313726 | ||
| Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles | Q39360706 | ||
| Selective recognition of co-assembled thrombin aptamer and docetaxel on mesoporous silica nanoparticles against tumor cell proliferation | Q39455745 | ||
| Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasound-targeted microbubble activation on VX2 rabbit liver tumors | Q39757882 | ||
| Physicochemical characterization of liposomes after ultrasound exposure - mechanisms of drug release. | Q41611364 | ||
| Diabetes and hepatocellular carcinoma: what role does diabetes have in the presence of other known risk factors? | Q43142490 | ||
| Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers | Q46948725 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbubble | Q6839290 |
| P304 | page(s) | 4763-4771 | |
| P577 | publication date | 2016-08-01 | |
| P1433 | published in | OncoTargets and Therapy | Q7092081 |
| P1476 | title | Docetaxel-loaded lipid microbubbles combined with ultrasound-triggered microbubble destruction for targeted tumor therapy in MHCC-H cells | |
| P478 | volume | 9 |
| Q57129161 | Advanced physical techniques for gene delivery based on membrane perforation |
| Q58790284 | Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro |
| Q91756096 | Effect of docetaxel-loaded lipid microbubble in combination with ultrasound-triggered microbubble destruction on the growth of a gastric cancer cell line |
| Q39200304 | Mechanical and Biological Effects of Ultrasound: A Review of Present Knowledge |
| Q64892310 | Microbubbles used for contrast enhanced ultrasound and theragnosis: a review of principles to applications. |
| Q59813114 | Targeted delivery of reduced graphene oxide nanosheets using multifunctional ultrasound nanobubbles for visualization and enhanced photothermal therapy |
Search more.